Shanghai Nianxing Industrial Co., Ltd
China
Product Name: IBUTILIDE
Price:
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang

122647-31-8

122647-31-8 structure

122647-31-8 structure

Name: IBUTILIDE
Chemical Name: ibutilide
CAS Number: 122647-31-8
Molecular Formula: C₂₀H₃₆N₂O₃S
Molecular Weight: 384.57600
Catalog: API Circulatory system medication Antiarrhythmic drug
Create Date: 2018-06-28 09:13:25
Modify Date: 2024-01-02 16:29:27
Ibutilide (U70226E free base), an action potential-prolonging antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells[1].

Name	ibutilide
Synonyms	MFCD01715410

Description	Ibutilide (U70226E free base), an action potential-prolonging antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells[1].
Related Catalog	Research Areas >> Cardiovascular Disease Signaling Pathways >> Membrane Transporter/Ion Channel >> Potassium Channel
In Vitro	Ibutilide is a potent IKr blocker with EC50 value of 20 nM at +20 mV in atrial tumor myocytes (AT-1) cells[1]. Ibutilide blocks IKr in cells expressing HERG+MDR11 to the same extent as cells expressing HERG alone (IC50: 22.5±0.9 vs 27.4±2.5 nM). However, cells expressing MDR17 show a marked resistance to Ibutilide (IC50: 105.3±1.42 nM vs 27.4±2.5 nM)[2].
In Vivo	Ibutilide prolongs cardiac repolarization in vitro and in vivo[1]. Ibutilide infusions (administered cumulatively in three doses, 0.01, 0.02 and 0.05 mg/kg i.v., each as a 10-min infusion) results in both polymorphic and monomorphic non-sustained ventricular tachycardia[3]. Animal Model: Fifteen adult mongrel dogs of either sex[1] Dosage: 0.01, 0.02 and 0.05 mg/kg Administration: Infusion Result: The action potential duration at 90% (APD90) prolongation with Ibutilide (0.01 mg/kg) was significantly greater in congestive heart failure (CHF) vs. controls. An increased dispersion of left–right ventricular APD90 was observed in CHF at 0.01 mg/kg, but not in controls.
References	[1]. Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects. Circulation. 1995 Mar 15;91(6):1799-806. [2]. B F McBride, et al. Influence of the G2677T/C3435T haplotype of MDR1 on P-glycoprotein trafficking and Ibutilide-induced block of HERG. Pharmacogenomics J. 2009 Jun;9(3):194-201. [3]. S S Chugh, et al. Altered response to Ibutilide in a heart failure model. Cardiovasc Res. 2001 Jan;49(1):94-102.

Density	1.099g/cm3
Boiling Point	522.4ºC at 760mmHg
Molecular Formula	C₂₀H₃₆N₂O₃S
Molecular Weight	384.57600
Flash Point	269.7ºC
Exact Mass	384.24500
PSA	78.02000
LogP	5.31780
Vapour Pressure	9.71E-12mmHg at 25°C
Storage condition	2-8°C

Hazard Codes	Xn
Risk Phrases	R22